You will automatically be redirected in 10 seconds. Or, you can click the link below:

https://www.streetinsider.com/Corporate+News/Viking+Therapeutics+%28VKTX%29+Presents+New+Data+from+Phase+1+Clinical+Trial+of+Dual+GLP-1GIP+Receptor+Agonist+VK2735+in+Oral+Presentation/22282639.html